Project Grant T32AI200946
- The National Institute of Allergy and Infectious Diseases, a division of the Department of Health and Human Services, awarded the University of Maryland, Baltimore $312,537 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 1, 2026, to support the Mechanisms Integrating Nervous and Immune Systems Training Program (MINISTP). The award funds a two-tiered training curriculum designed to prepare three graduate students and two post-doctoral researchers for up to...
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $201,600 on August 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support an Immunology Training Program. The program establishes a collaboration across three Houston-area institutions—Baylor College of Medicine, University of Texas Health Science Center at Houston, and MD Anderson Cancer Center—to train predoctoral immunology researchers. Four carefully selected...
- The National Institute of Allergy and Infectious Diseases awarded Baylor College of Medicine $452,128 on September 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research training in infection and immunity. The award funds the Baylor College of Medicine Research Training in Infection and Immunity program, which will train four MD, MD/PhD, or PhD postdoctoral fellows annually for two years of mentored research training. The program provides a...
- The National Institute of Allergy and Infectious Diseases awarded The University of Texas Southwestern Medical Center $191,987 on June 15, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to establish a postdoctoral research training program in infectious diseases. The UT Southwestern Infectious Diseases Research Training Program supports two postdoctoral physician-scientist trainees annually for two-year training periods. The program recruits physician-scientists...
- The National Institute of Allergy and Infectious Diseases awarded the University of Arizona $368,681 on May 13, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to establish and expand the National Summer Undergraduate Research Project (NSURP), an eight-week virtual summer research program in biomedical microbiology and immunology. NSURP matches underrepresented minority undergraduate students nationwide with faculty mentors to conduct remote research from any...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded $504,547 to The Regents of the University of California, San Francisco (UCSF) on August 6, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855, Project Grant T32AI200899). The award funds the UCSF Immunology Training Program (ITP), which provides structured training to approximately 5–6 graduate students per year (3 per cohort) and 2–3...
- The National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services, awarded $571,412 to the University of Maryland, College Park on June 11, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds research into the regulation of bacterial physiology and infections through linear diribonucleotides and RNA degradation. The project will characterize how diribonucleases and triribonucleases bind their respective...
- The National Institute of Allergy and Infectious Diseases awarded The University of Kentucky Research Foundation $144,825 on August 10, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support predoctoral trainee stipends and related costs for a transdisciplinary training program in microbiology and immunology. The program supports three predoctoral trainees per year, selected from PhD candidates in their third or fourth year of study across 18 faculty mentors at...
- The National Institute of Allergy and Infectious Diseases awarded New York University $508,500 on April 22, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support research investigating how myeloid cells, particularly neutrophils, regulate plasma membrane homeostasis to control decisions between functional immune programs including migration, phagocytosis, and netosis. The research, conducted as a postdoctoral project at New York University School of Medicine...
- The National Institute of Allergy and Infectious Diseases awarded Albert Einstein College of Medicine a Project Grant totaling $1,486,296 on August 12, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds research into the human antibody response to Cryptococcus neoformans and survival outcomes in HIV-associated cryptococcal meningoencephalitis, a devastating opportunistic infection of the central nervous system that occurs predominantly in people...
The National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, awarded the University of Oklahoma Health Sciences Center $233,001 on August 1, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to support an interdisciplinary training program in immunity and microbial infection. The award funds a five-year training program that will provide predoctoral research training to five trainees per year. The program trains scientists in immunology and its relationship to infectious diseases, alongside related disciplines including biochemistry, physiology, and cell biology, with the goal of developing investigators capable of contributing to basic, translational, and clinical research in immunity and microbial infection. Trainees are recruited nationally and internationally through the University of Oklahoma Graduate Program in Biomedical Sciences and selected competitively after passing qualifying exams. Appointments are reviewed annually and competitively renewed, with a maximum of three years of support per predoctoral trainee. The program encompasses faculty from the University of Oklahoma Health Sciences Center and the Oklahoma Medical Research Foundation who focus on immunology and microbial pathogenesis. Performance of work occurs in Oklahoma City, Oklahoma. The period of performance runs from August 1, 2026, through July 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $233.0k | 7/30/26 |